Back to search results

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

This study is looking at two different ways to help very premature babies (born at 28 weeks or less) who need a medicine called surfactant to help their lungs. The study compares using a video camera (Video Laryngoscopy) versus looking directly (Direct Laryngoscopy) to guide a small tube for giving surfactant. The main goal is to see which method is more successful at placing the tube correctly on the first try. You might be able to join if your baby was born at 28 weeks or less, was successfully resuscitated, and needs surfactant within the first 36 hours of life. The study plans to include 100 babies, but its current status is unclear.

Study design
This is an interventional study comparing two procedures: Video Laryngoscopy and Direct Laryngoscopy. It aims to enroll 100 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, first attempt success, is measured during the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07426016

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

Recruiting
NAAges 0–3InterventionalTreatment
University of Texas Southwestern Medical Center
~100 participants
Updated 2026-06-15 on ClinicalTrials.gov
What's tested:Video LaryngoscopyDirect Laryngoscopy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Rate of first attempt success
Measured over During procedure

Conditions

Respiratory Distress Syndrome (Neonatal)
Surfactant Deficiency Syndrome Neonatal

Explore related trials

Respiratory Distress SyndromeSurfactant Deficiency Syndrome

NCT07426016

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Parkland Hospital

    Dallas, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Chokshi, MD · PRINCIPAL_INVESTIGATOR · UT Southwestern
  • Shalini Ramachandran, MD · PRINCIPAL_INVESTIGATOR · UT Southwestern

Who to contact

Principal Investigator, MD
[email protected]
214-648-3383
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Infants born ≤28 weeks GA successfully resuscitated in the delivery room (DR) and maintained on CPAP • Need for surfactant in the first 36 hours of life based on clinical assessment and/or meeting threshold per unit protocol

Exclusion

Infants born ≥29 weeks GA or
Infants with known congenital anomalies or
Infants who are determined by the primary care team to receive comfort care only or
Infants who are intubated at any time prior to surfactant administration

What this trial measures

  • Rate of first attempt successDuring procedure